Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells

Current Microbiology

Volumn 38, Issue 6, 1999, Pages 342-348

  Champney, W Scott ^a   Tober, Craig L ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BACTERIUM LYSATE; CARBONIC ACID; CLARITHROMYCIN; CLARITHROMYCIN DERIVATIVE; KETOLIDE; MACROLIDE; TRITIUM; URIDINE;

AMINO ACID SUBSTITUTION; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RIBOSOME SUBUNIT; RNA TRANSLATION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBONATES; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; CULTURE MEDIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; RIBOSOMES; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS; TRITIUM;

EID: 0033033857     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006814     Document Type: Article

References (23)

1. Anderson M, Bergeron J, Masamune H, Norcia M, Retsema J, Sutcliffe J (1995) Activity of CP-227, 182, a des-cladinose 3 keto clarithromycin derivative, in cell free peptide synthesis and ribosome binding studies. Abstracts Frontiers in Translation Conference, p 145 American Society for Microbiology, Washington, D.C.
2. B resistance phenotype. J Antimicrob Chemother 40:85-90
3. Champney WS, Burdine R (1998) Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells. Curr Microbiol 36:119-123
4. Champney WS, Burdine R (1998) Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells. Microb Drug Resist 4:169-174
5. Champney WS, Tober CL (1998) Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by eleven different ketolide antibiotics. Curr Microbiol 37:418-425
6. Champney WS, Tober CL, Burdine R (1998) A comparison of the inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by nine different macrolide antibiotics. Curr Microbiol 37:412-417
7. Chu DT, Plattner JJ, Katz L (1996) New directions in antibacterial research. J Med Chem 39:3853-3874
8. Ednie LM, Jacobs MR, Appelbaum PC (1997) Comparative antianaerobic activities of the ketolides HMR 3647 (RU66647) and HMR 3004 (RU 64004). Antimic Agents Chemother 41:2019-2022
9. Fernandes PB, Baker WR, Freiberg LA, Hardy DJ, McDonald EJ (1989) New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. Antimic Agents Chemother 33:78-81
10. Jett BD, Hatter KL, Huycke M, Gilmore MS (1997) Simplified agar plate method for quantifying viable bacteria. BioTechniques 23:648-650
11. Kirst HA (1993) Semi-synthetic derivatives of erythromycin. Prog Med Chem 30:57-88
12. Mao JC-H, Putterman M (1969) The intermolecular complex of erythromycin and the ribosome. J Mol Biol 44:347-361
13. Michaels GA (1972) Ribosome maturation of Escherichia coli growing at different growth rates. J Bacteriol 107:385-387
14. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
15. Omura S, Tanaka H (1984) Production and antimicrobial activity of macrolides. In: Omura S (ed) Macrolide antibiotics. Orlando, FL: Academic Press, pp 3-35
16. Pankuch GA, Visalli MA, Jacobs MR, Appelbaum PC (1998) Susceptibilities of penicillin-and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU66647), a new ketolide, compared with susceptibilities to 19 other agents. Antimic Agents Chemother 42:624-630
17. Reinert RR, Bryskier A, Lutticken R (1998) In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. Antimic Agents Chemother 42:1509-1511
18. Rosato A, Vicarini H, Bonnefoy A, Chantot J-F, Leclercq R (1998) A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. Antimic Agents Chemother 42:1392-1396
19. Sakakibara H, Omura S (1984) Chemical modification and structure-activity relationship of macrolides. In: Omura S (ed) Macrolide antibiotics. Orlando, FL: Academic Press, pp 85-125
20. Turco E, Altruda F, Ponzetto A, Mangiarotti G (1974) Ribosome biosynthesis in Escherichia coli. Concerning the limiting step. Biochemistry 13:4752-4757
21. Whitman MS, Tunkel AR (1992) Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect Control Hosp Epidemiol 13:357-368
22. Williams JD, Sefton AM (1993) Comparison of macrolide antibiotics. J Antimic Chemother 31 (suppl. C):11-26
23. Zuckerman JM, Kaye KM (1995) The newer macrolides. Azithromycin and clarithromycin. Infect Dis Clin N Am 9:731-745